Dr. Mark Kreimer, DO

Dr. Kreimer practices at Boca Raton Regional Hospital in Boca Raton, Florida, part of Baptist Health South Florida.

Dr. Kreimer's NPI, 1255735221, was assigned on October 20, 2014. Dr. Kreimer graduated from New York College of Osteo Medicine of New York Institute of Technology in 2014. Dr. Kreimer holds New York license 288572.

Dr. Kreimer's primary practice is Boca Raton Regional Hospital, at 800 Meadows Rd, Boca Raton, FL 33486 in Palm Beach County. The practice phone is (561) 955-4200.

Dr. Kreimer's primary practice is Boca Raton Regional Hospital in Boca Raton, Florida, part of Baptist Health South Florida. Dr. Kreimer is also affiliated with Lenox Hill Hospital. The medical group on file is Paragon Contracting Services. Dmand AI also links Dr. Kreimer to 2 more hospitals, 11 medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kreimer practices, 7 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Kreimer's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Kreimer is licensed in New York.

CMS data shows 469 Medicare services from Dr. Kreimer across 5 procedure codes in 2024, for 413 Medicare patients. Medicare paid $65,330 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 413 Medicare patients who saw Dr. Kreimer in 2024. The largest group is 75 to 84, with 156 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 38% are also on Medicaid. Their average risk score is 2.28, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kreimer's median patient age at 55, with 57% women.

In 2024, Dr. Kreimer wrote 110 Medicare Part D claims for 65 patients. 89% of them were for generic drugs. CMS names the drug for 54 of them, across 3 drugs with 11 or more claims each, at $652 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Kreimer for performance year 2024, reported through an alternative payment model (APM). Dr. Kreimer accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Kreimer, published from 2023 to 2025. Dr. Kreimer has published most often in Front Med (Lausanne). Dr. Kreimer's most frequent co-authors are Eric D. Osgood, MD, Christopher Dean Beaty, MD and Bruce Kendrick Patterson, MD.

CMS Open Payments shows 2 general payments to Dr. Kreimer from 2 drug and device companies from 2019 to 2024. Food and beverage make up the largest share, 100% of the total. Allergan Inc. paid the most, $129.

Dr. Kreimer graduated from New York College of Osteo Medicine of New York Institute of Technology in 2014.